Department of Hematology, Selcuk University, Faculty of Medicine, Konya, Turkey.
Department of Medical Genetic, Konya City Hospital, Konya, Turkey.
Transfus Apher Sci. 2023 Aug;62(4):103710. doi: 10.1016/j.transci.2023.103710. Epub 2023 Apr 6.
One of the rarest types of hereditary thrombocytopenia is the MYH9-related disorder. This spectrum of disorders is characterized by large platelets with or without leukocyte inclusion bodies, a decrease in the total number of platelets, and autosomal dominant inheritance. Proteinuric nephropathy that frequently progresses to end-stage renal failure, as well as the beginning of progressive high-frequency sensorineural hearing loss in young adults, is also associated with MYH9-related disorder. In this case report, we presented three family members who had thrombocytopenia and in whom a heterozygous novel 22 bp deletion (c.4274_4295del) was detected which is located in exon 31 of the MYH9 gene. There was no evidence of bleeding in the family members we presented and thrombocytopenia was detected incidentally. Additionally, renal failure, hearing loss, presenile cataracts, and clinical symptoms were not detected in these family members. This novel mutation detected in the MYH9 gene has not been reported in the literature before.
遗传性血小板减少症中最罕见的类型之一是 MYH9 相关疾病。该疾病谱的特征是大血小板,伴有或不伴有白细胞包涵体,血小板总数减少,呈常染色体显性遗传。常伴有蛋白尿性肾病,进而进展为终末期肾衰竭,以及年轻人开始出现进行性高频感觉神经性听力损失,也与 MYH9 相关疾病有关。在本病例报告中,我们介绍了三位血小板减少症患者,他们均携带杂合的新型 22bp 缺失(c.4274_4295del),该缺失位于 MYH9 基因的外显子 31 中。我们介绍的这些家庭成员没有出血迹象,血小板减少是偶然发现的。此外,这些家庭成员未检测到肾衰竭、听力损失、早发性白内障和临床症状。该 MYH9 基因中检测到的新型突变以前在文献中没有报道过。